Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Nuclear Medicine and Biology

• Publication date

  1997-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0969-8051(97)00023-1PMID 9316077
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacologic properties of (−)-3PPP (preclamol) in man

  2005cited by this paper
• The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity

  2005cited by this paper
• Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP

  2004cited by this paper
• On the quantitative structure-activity relationships of meta-substituted (S)-phenylpiperidines, a class of preferential dopamine D2 autoreceptor ligands: modeling of dopamine synthesis and release in vivo by means of partial least squares regression.

  1995cited by this paper
• AN EFFICIENT SYNTHESIS OF THE NOVEL DOPAMINE AUTORECEPTOR ANTAGONIST S-(-)-OSU6162, VIA PALLADIUM CATALYZED CROSS-COUPLING REACTION

  1994cited by this paper
• Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.

  1994cited by this paper
• Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levels

  1993cited by this paper
• Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

  1991cited by this paper
• Striatal kinetics of [11C]‐(+)‐nomifensine and 6‐[18F]fluoro‐L‐dopa in Parkinson's disease measured with positron emission tomography

  1990cited by this paper
• A Two-Compartment Description and Kinetic Procedure for Measuring Regional Cerebral [11C]Nomifensine Uptake Using Positron Emission Tomography

  1990cited by this paper
• Synthesis of L- and D-[methyl-11C]methionine.

  1987cited by this paper
• (+)-AJ 76 and (+)-UH 232: Central stimulants acting as preferential dopamine autoreceptor antagonists

  1986cited by this paper
• Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.

  1977cited by this paper
• The Conversion of Phenols to Thiophenols via Dialkylthiocarbamates1

  1966cited by this paper

• Pharmaco-fMRI in Patients With Traumatic Brain Injury: A Randomized Controlled Trial With the Monoaminergic Stabilizer (–)-OSU6162

  2019cites this paper
• PET microdosing of CNS drugs

  2017cites this paper
• The role of the dopamine system in the ability of (-)-OSU6162 to reduce voluntary alcohol drinking and binge-eating in the rat

  2017cites this paper
• IMAGING DRUG DELIVERY TO THE CNS USING TRANSLATIONAL POSITRON EMISSION TOMOGRAPHY STUDIES

  2013cites this paper
• Modeling of PET data in CNS drug discovery and development

  2013cites this paper
• Radiosynthesis of [5-[ 11C]methanesulfonyl-2-((S)-2,2,2- trifluoro-1-methyl-ethoxy)-phenyl]-[5-(tetrahydro-pyran-4-yl)-1, 3-dihydro-isoindol-2-yl]-methanone ([ 11C]RO5013853), a novel PET tracer for the glycine transporter type i (GlyT1)

  2011cites this paper
• 41 11 C: Labeling Chemistry and Labeled Compounds

  2011cites this paper
• Rapid communication Stimulating and inhibitory effects of the dopamine ''stabilizer'' (2)-OSU6162 on dopamine D2 receptor function in vitro

  2007cites this paper
• Stimulating and inhibitory effects of the dopamine “stabilizer” (−)-OSU6162 on dopamine D2 receptor function in vitro

  2007cites this paper
• Oxidation of aromatic lithium thiolates into sulfinate salts: an attractive entry to aryl sulfones labeled with carbon-11.

  2006cites this paper
• The Dopamine Stabilizers (S)-(-)-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-Methanesulfonylphenyl)-1-propyl-piperidine (ACR16) Show High in Vivo D2 Receptor Occupancy, Antipsychotic-Like Efficacy, and Low Potential for Motor Side Effects in the Rat

  2006cites this paper
• Motor effects of a dopamine stabilizer (GMC1111) in primate models of Parkinson and hemiparkinsonism.

  2003cites this paper
• Historical aspects and future directions

  2003cites this paper
• Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development

  2003cites this paper
• Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.

  2001cites this paper
• Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys.

  2001cites this paper
• Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions.

  2000cites this paper
• Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.

  1999cites this paper
• Effects of the substituted (S)‐3‐phenylpiperidine (−)‐OSU6162 on PET measurements in subhuman primates: Evidence for tone‐dependent normalization of striatal dopaminergic activity

  1998cites this paper